Vivanza Biosciences Ltd — Important, 25-09-2025: Company Update

Vivanza Biosciences held its 43rd Annual General Meeting, where shareholders considered and voted on several key resolutions. These included the adoption of the audited standalone and consolidated financial statements for the fiscal year ended March 31, 2025. Shareholders also addressed the re-appointment of a director liable to retire by rotation and the regularization of two additional directors. Other agenda items involved appointing a secretarial auditor for a five-year term and a significant alteration to the company's Memorandum of Association. These decisions are vital for the company's governance, financial transparency, and future business scope. Voting was conducted through e-voting, with combined results expected within 48 hours.